Aesthetics Regulation Won’t Fix This Industry. Insurers Might.

It may sound counterintuitive, but insurers are arguably the most powerful actor in the room when it comes to raising standards in the aesthetic industry. They are the one party with both the financial motivation and the leverage to move the whole industry toward better consent practice before the claims landscape forces it.

The aesthetic industry does not have a regulation gap. It has a regulation illusion. Rules exist, guidance has been issued, membership bodies have published standards, and the sector has continued largely as before. The party with the genuine power to change that is not a government body or a professional association. It is insurers, and most of them have not yet used that power in any meaningful way.

The timeline speaks for itself. The Keogh Review identified the core problems in 2013. A consultation on licensing non-surgical procedures ran in 2023. The government's response, published in August 2025, was still presenting proposed frameworks. In February 2026, a House of Commons committee was still noting that regulation had not kept pace with demand. Thirteen years of reviews, consultations, and proposed frameworks, and the sector remains fragmented, inconsistently governed, and largely self-policing.

The Limits of Aesthetics Regulation

The limits of rule-making in this sector are visible in even the clearest cases. In the UK, advertising Botox to the public is prohibited under the Human Medicines Regulations 2012 and Committee of Advertising Practice (CAP) Code rule 12.12. The rule is unambiguous, yet the Advertising Standards Authority (ASA) and CAP keep having to reissue guidance and publish rulings against breaches because those breaches keep happening. Industry membership bodies like the Joint Council of Cosmetic Practitioners (JCCP), the General Medical Council (GMC), British College of Aesthetic Medicine (BCAM), and British Association of Medical Aesthetic Nurses (BAMAN) provide guidance but do not enforce legal rules amongst their members.

That is not a failure of the rule. It is a demonstration of what happens when enforcement is inconsistent and consequences are negligible to non-existent. A sector can look regulated on paper while operating very differently in practice. Voluntary registers have some value, but they cannot compel behaviour change in a sector where membership is optional, departure is consequence-free, and commercial pressure consistently outweighs professional guidance.

[Insurer's] leverage is financial, immediate, and non-negotiable in a way no voluntary membership body can hope to replicate.

Insurers operate on entirely different terms. They do not need practitioners to be ethically motivated or professionally engaged. They need practitioners to want cover, and that is a conversation that happens at renewal, on terms the insurer sets. Underwriting requirements, policy conditions, and portfolio standards are already shaping what counts as defensible practice in this sector. That leverage is financial, immediate, and non-negotiable in a way no voluntary membership body can hope to replicate, which makes insurers one of the few parties capable of converting known risks into operational requirements rather than aspirational guidance.

The claims data points clearly to where those requirements should focus. Most cosmetic claims do not arise from surgical error or product failure. They arise from consent disputes, expectation gaps, and patients who were not adequately informed before a procedure that did not deliver what they hoped for. Psychological risk sits at the centre of that pattern.

Physical risks are disclosed as standard because failing to disclose them creates claims exposure. Psychological risks belong in the same conversation.

Conditions like Body Dysmorphic Disorder (BDD) are estimated to affect roughly one in five patients seeking cosmetic procedures and are strongly associated with poor outcomes after treatment, even when the procedure itself is clinically unremarkable. Physical risks are disclosed as standard because failing to disclose them creates claims exposure. Psychological risks belong in the same conversation, for exactly the same reason, and their consistent absence from cosmetic consent processes is a gap the claims data has been signalling for years.

Requiring documented psychological risk disclosure as a condition of cover is operationally achievable for any practice, places no greater burden on practitioners than existing physical risk disclosure, and addresses a recurring claim driver that voluntary guidance has failed to move. The aesthetic industry has spent over a decade waiting for external standards to arrive. Insurers do not need to wait. They are already setting standards. The question is whether those standards reflect what the claims data actually shows, or whether they continue to leave a known and addressable risk unmanaged.